What is the Difference Between Pneumococcal Vaccine and Flu Vaccine?

🆚 Go to Comparative Table 🆚

The pneumococcal vaccine and the flu vaccine are both important for protecting against respiratory illnesses, but they serve different purposes and target different pathogens.

The pneumococcal vaccine protects against pneumonia, meningitis, and bloodstream infections caused by the Streptococcus pneumoniae bacteria. There are two main types of pneumococcal vaccines:

  1. Pneumococcal conjugate vaccine (PCV13): Recommended for children under two years.
  2. Pneumococcal polysaccharide vaccine (PPSV23): Recommended for individuals at higher risk of pneumococcal infections and adults 65 years and older.

The flu vaccine, on the other hand, protects against influenza viruses that cause various symptoms such as cough and body ache. The strains of influenza viruses can vary from year to year, so the flu shot is updated annually to combat newly emerging strains. It is recommended that individuals at high risk of complications from influenza, such as the elderly, young children, and those with existing medical conditions, receive a flu shot every year.

There are several key differences between the pneumococcal and flu vaccines:

  • Targeted pathogens: Pneumococcal vaccines target Streptococcus pneumoniae bacteria, while flu vaccines target influenza viruses.
  • Diseases prevented: Pneumococcal vaccines protect against pneumonia, meningitis, and bloodstream infections, while flu vaccines protect against various influenza virus-related symptoms.
  • Vaccine types: Pneumococcal vaccines are either conjugate (PCV13) or polysaccharide (PPSV23), while flu vaccines are typically updated annually to target the most recent strains of influenza viruses.
  • Administration: For most individuals, the pneumococcal vaccine may only need to be given once in a lifetime, while the flu vaccine is updated annually and should be received every year.

Simultaneous administration of both vaccines is considered safe, effective, and economically advantageous. In some cases, the combination of influenza and pneumococcal vaccines has been shown to have an additive preventive effect in reducing the need for hospital admission for influenza and pneumonia.

Comparative Table: Pneumococcal Vaccine vs Flu Vaccine

Here is a table comparing the differences between the pneumococcal vaccine and the flu vaccine:

Vaccine Targeted Disease Efficacy Vaccine Types Administration Coverage
Pneumococcal Pneumococcal infections, such as pneumonia, meningitis, and sepsis PPSV23: 60-70% effective in preventing invasive disease caused by serotypes in vaccine; PCV13: 45.6% efficacy against vaccine-type pneumococcal pneumonia, 45.0% efficacy against vaccine-type nonbacteremic pneumococcal pneumonia, 75.0% efficacy against vaccine-type IPD in adults PPSV23 (Pneumovax 23), PCV13 (Prevnar 13) Based on age and medical conditions
Flu Influenza Varies depending on the vaccine and the season Trivalent, quadrivalent, and other formulations Annual vaccination recommended for persons 6 months of age and older Varies depending on the season and vaccine formulation
  • The pneumococcal vaccine targets pneumococcal infections, such as pneumonia, meningitis, and sepsis, while the flu vaccine targets influenza.
  • Pneumococcal vaccine efficacy varies depending on the type of vaccine: PPSV23 is 60-70% effective in preventing invasive disease caused by serotypes in the vaccine, and PCV13 has varying levels of efficacy against different types of pneumococcal pneumonia and invasive pneumococcal disease. Flu vaccine efficacy varies depending on the vaccine formulation and the season.
  • There are two types of pneumococcal vaccines available for clinical use: PPSV23 (Pneumovax 23) and PCV13 (Prevnar 13). There are various formulations of flu vaccines, including trivalent and quadrivalent.
  • Pneumococcal vaccine administration is based on age and medical conditions. Flu vaccination is recommended annually for persons 6 months of age and older.
  • Pneumococcal vaccine coverage is not as high as flu vaccine coverage, with only about 60.1% of persons aged 65 years and older receiving the vaccine in 2008. Flu vaccination rates for this group were 65.0% in 2009.